October 29, 2009

BioCision Signs Distribution Deal with Capital Biosciences

MILL VALLEY, Calif. -- BioCision LLC, the CoolRack™ company, announced today that is has reached an agreement with Capital Biosciences Inc. for the distribution of BioCision's products, which standardize the handling and processing of temperature-sensitive samples.

Capital BioSciences joins our growing network of worldwide distributors and we are excited about this new partnership,” said BioCision CEO Rolf Ehrhardt, M.D., Ph.D. “We look forward to providing Capital Biosciences' customers with a full line of easy-to-use and inexpensive benchtop tools that eliminate temperature variation in lab samples, an important and often overlooked variable in scientific research.”

BioCision's products can be ordered from Capital Biosciences at http://www.capitalbiosciences.com/category/show/thermo-conductive-benchtop-organizers.html.

Capital Biosciences, based in Rockville, MD, distributes a range of biological products, including cell immortalization products, clinically defined human tissue, cDNA ORF clones, pre-made adenoviruses, purified proteins, and viral expression systems. It also provides services such as custom recombinant adenovirus production, custom recombinant lentivirus production, protein detection and quantification and stable cell line production for academic and government research institutes, and the pharmaceutical and biotechnology industries.

BioCision is the leading maker of portable benchtop tools for temperature- sensitive biomedical samples and experiments. Its highly thermo-conductive CoolRack enables easy standardization of sample cooling, snap freezing, heating, thawing. Along with CoolRacks, BioCision's portable benchtop coolers, freezers, and thermally conductive platforms bring portability and all-day temperature control to the benchtop, increasing reproducibility and accuracy in scientific experiments.

Since BioCision's founding in late 2007, the company has commercialized more than 40 products now adopted by leading pharmaceutical and biotechnology companies, contract research organizations, and academic and healthcare institutions worldwide. BioCision's customers include Amgen Inc., The Burnham Institute, Harvard University, Genentech Inc., Novartis AG, Lawrence Livermore Laboratory, Medimmune, Merck & Co. Inc., Pfizer Inc. and Stanford University, among many others.


BioCision LLC, the CoolRack™ company, is the leading developer of portable benchtop tools for all temperature-sensitive biomedical samples. Its patent-pending products enable researchers to achieve high pre-analytical sample reproducibility and consistency - experiment to experiment, lab to lab and site to site. BioCision's highly thermo-conductive CoolRack and complementary product lines are widely used by researchers in the pharmaceutical, biotechnology, academic, and health care industries worldwide. BioCision was founded in 2007 by a group of scientists, biomedical engineers and drug discovery experts. For more information, visit www.biocision.com.


CoolCell® Controlled-rate cell freezing equivalent to CRFs

Contact BioCision:

About Us
Contact Us
Privacy Policy

© Copyright 2018, BioCision.
All rights reserved

BioCision is a life science research and development company that develops products and solutions for process standardization throughout the healthcare industry through the application of advanced thermal regulation principles and technologies. The intuitive design and interconnectivity of BioCision products enables researchers, clinicians and manufacturers to protect the integrity of temperature-sensitive therapeutics, biological samples, and biomaterials. By comprehensively addressing temperature stability, BioCision strives to improve the success of therapeutic discovery and development and enable effective care delivery.

Help 1-800-367-4887